Sientra, a Santa Barbara medical device company focused on plastic surgery and aesthetics medicine, said it raised a $85 million second round of financing — one of the largest private funding rounds in the medical device sector.
Sientra also announced that it has acquired the assets of Silimed Inc., a leading developer of plastic surgery implants for both cosmetic and reconstructive surgery.
The round was co-led by OrbiMed Advisors and Clarus Ventures, and included Goldman Sachs and TIAA-CREF.
Sientra plans to use some of the proceeds to finance the Silimed acquisition.
Statement is here. We couldn’t find a Web site for Sientra.
VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn More
